ANDEMBRY® (garadacimab-gxii)
| Full Name | ANDEMBRY® (garadacimab-gxii) |
| Drug | garadacimab-gxii |
| Manufacturer | CSL Behring |
| Route of Administration | Subcutaneous |
| Site of Care | Home |
| Approved Indication | Prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older |
| Disease | Hereditary Angioedema (HAE) |
| Therapeutic Area | Allergy & Immunology |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-356-4252 |
| Fax Number | 847-631-6918 |
| Product Website | andembryhcp.com |
| Patient Resources | HAEA |